HIGHLIGHTS
- who: Emily Pickering from the School of Pharmacy, University of Queensland, PACE QLD, Australia have published the article: A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain, in the Journal: (JOURNAL) of 20/Nov/2020
- what: Objective This study explored the safety tolerability and efficacy of a (PEA) formulation in treating diabetic-related (PNP). The aim of the current clinical study was to determine whether an enhanced bioavailable formulation of PEA was safe, tolerable and effective for managing DPNrelated pain and, moreover, and secondarily, this formulation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.